Propper Manufacturing Announces FOBT Agreement With GNYHA Services

NEW YORK, March 11, 2015 /PRNewswire/ -- Propper Manufacturing Company has been awarded a direct group purchasing agreement (GNYHA-LA-030) by GNYHA Services, Inc. effective March 1, 2015, that will offer the supply of Seracult^® fecal occult blood tests to GNYHA at fixed three (3) year pricing. The agreement will also extend to members of GNYHA Services' non-acute-focused sister GPO Essensa.

"Achieving an agreement with GNYHA Services has been a priority for us. We're proud to offer our products through their contract portfolio and support their members in improving public health," said Joe Looney, President & CEO of Propper Manufacturing Company. Population screening for colorectal cancer (CRC) is a quality metric put forth by the Centers for Medicare & Medicaid Pioneer ACO Model, as well as the Department of Health and Human Services, and Seracult has a proven history as a diagnostic aid for CRC.

The agreement is structured to provide GNYHA and Essensa members with firm, negotiated pricing and a recognized, high-quality product. FOBT is a simple, reliable, and non-invasive method for the early detection of diseases of the colon and rectum. The test works by detecting whether occult, meaning hidden, hemoglobin from blood is present in a stool sample. As recommended by the United States Preventative Services Task Force, healthcare professionals use FOBT as a screening tool for CRC in the annual examinations of approximately 8 million patients nationally. Colorectal cancer is highly treatable if detected early.

Seracult FOBT has served healthcare providers for over 30 years and is available in a variety of configurations to service all of the settings in which FOBT tests are administered. The performance of the test has been verified by independent studies and has been used in community screening programs since its launch.

About Propper Mfg. Co., Inc.

Propper manufactures industry leading medical devices in the USA (Long Island City, NY) that are used in the prevention of disease. Founded in 1935 as a medical supply company, Propper garnered a reputation for innovation in autoclave testing and continues to develop top performing and environmentally safe sterilization indicators. In addition to the Seracult line of in-vitro diagnostic tests, Propper is a trusted manufacturer of sterility assurance products, diagnostic instruments and surgical supplies. More information about Propper can be found on their website: www.proppermfg.com.

About GNYHA Services, Inc.

GNYHA Services is a strategic group purchasing organization and supply chain resource for hospitals and health systems. Its leading industry experts identify data-driven methods to support members in lowering total costs while improving outcomes.

Founded in 1978, GNYHA Services was created to provide supply chain solutions for hospitals in the Greater New York area. The company has since grown nationally and now serves more than 300 hospitals and health systems in New York, New Jersey, Connecticut, Massachusetts, and Puerto Rico.

About Essensa

Essensa is the fastest-growing national GPO delivering procurement solutions, supply chain efficiencies, and greater operating margins to sports and recreation leagues, as well as hotels, spas, country clubs, and entertainment venues. Essensa members have access to a $41 billion portfolio comprising 2,000 contracts through more than 900 suppliers. With value-added services, including the Employee Discount Program, complimentary publications, regular contract updates, and exceptional customer service and support staff, Essensa is the clear choice to make a real impact on expenses.

Logo - http://photos.prnewswire.com/prnh/20150310/180812LOGO 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/propper-manufacturing-announces-fobt-agreement-with-gnyha-services-300048459.html

SOURCE Propper Manufacturing Company, Inc.